TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice.
Journal Information
Full Title: Cardiol J
Abbreviation: Cardiol J
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest: Krzysztof J. Filipiak — Adamed, Alfasigma, AstraZeneca, Bausch Health, Bayer, Boehringer Ingelheim, Krka, Mundipharma, Mylan, Novartis, Sandoz, Servier, Viatris; Miguel Camafort Babkowski — Adamed; Matteo Cameli — Adamed, AstraZeneca, Novo Nordisk, General Electric; Stefano Carugo — Adamed; Claudio Ferri — Adamed; Djamshid B. Irisov — Adamed; Krzysztof Narkiewicz — Adamed, Bausch Health, Berlin-Chemie/Menarini, Egis, Gedeon Richter, Idorsia, Krka, Medtronic, Novo Nordisk, Polpharma, Recordati, Servier; Ulugbek Nizamov — Adamed; Leopoldo Pérez de Isla — Adamed, Almirall, Amgen, Bayer, Esteve, Ferrer, MSD, Mylan, Novartis, Novo Nordisk, Organon, Pfizer, Sanofi, Servier; Anna Tomaszuk-Kazberuk — Adamed, Boehringer Ingelheim, Krka, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda; Andrea Ungar — Adamed; Aleksandra Gąsecka — Adamed, AstraZeneca, Bausch Health, Berlin-Chemie/Menarini, Krka, Servier."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025